A COMPARATIVE STUDY OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (NSC79037) AND IMIDAZOLE CARBOXAMIDE (NSC 45388) WITH VINCRISTINE (NSC 67574) IN THE PALLIATION OF DISSEMINATED MALIGNANT MELANOMA = ETUDE COMPARATIVE DE LA CHLORO-2 ETHYL-1 CYCLOHEXYL-5 NITROSO-1 UREE (NSC79037) ET DE L'IMIDAZOLE CARBOXAMIDE (NSC45388) ASSOCIE A LA VINCRISTINE (NSC67574) DANS LE TRAITEMENT DU MELANOME MALIN DISSEMINEAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 11; PP. 2432-2434; BIBL. 5REF.Serial Issue

CLINICAL EVALUATION OF 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388), MELPHALAN (NSC-8806), AND HYDROXYUREA (NSC-32065) IN THE TREATMENT OF DISSEMINATED MALIGNANT MELANOMAAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 3; PP. 369-372; BIBL. 7REF.Serial Issue

PHASE II STUDY OF AN AZIRIDINYLBENZOQUINONE (AZQ) IN DISSEMINATED MALIGNANT MELANOMA = ESSAI PHASE II D'UNE AZIRIDINYLBENZOQUINONE (AZQ) DANS LE MELANOME MALIN DISSEMINECREAGAN ET; SCHUTT AJ; AHMANN DL et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 12; PP. 2089-2090; ABS. ENG; BIBL. 6 REF.; GRAPHArticle

PHASE II STUDY OF HIGH-DOSE MEGESTROL ACETATE IN PATIENTS WITH ADVANCED MALIGNANT MELANOMACREAGAN ET; SCHUTT AJ; AHMANN DL et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 5; PP. 1239-1240; BIBL. 5 REF.Article

PHASE II STUDY OF THE COMBINATION OF VINBLASTINE, BLEOMYCIN, AND CISPLATIN IN ADVANCED MALIGNANT MELANOMACREAGAN ET; AHMANN DL; SCHUTT AJ et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 3; PP. 567-569; BIBL. 5 REF.Article

EVALUATION OF VP-16 AND THE COMBINATION OF ADRIAMYCIN AND VINCRISTINE IN ADVANCED BREAST CANCER.EAGAN RT; AHMANN DL; BISEL HF et al.1976; ONCOLOGY; SWITZ.; DA. 1976; VOL. 33; NO 3; PP. 146-148; BIBL. 12 REF.Article

DISSEMINATED BREAST CANCER: EVALUATION OF HORMONAL THERAPY UTILIZING STILBESTROL AND MEDROGESTONE (AY-62022) SINGLY AND IN COMBINATION = CANCER DU SEIN DISSEMINE: VALEUR DE LA THERAPEUTIQUE HORMONALE PAR STILBOESTROL ET MEDROGESTONE (AY-62022) SEULES OU ASSOCIEESAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 3; PP. 651-653; BIBL. 11REF.Miscellaneous

PHASE II CLINICAL TRIAL OF ISOPHOSPHAMIDE (NSC-109724) IN PATIENTS WITH ADVANCED BREAST CANCERAHMANN DL; BISEL HF; HAHN RG et al.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 6; PP. 861-865; BIBL. 3 REF.Article

A CLINICAL TRIAL ADRIAMYCIN (NSC 123127) IN ADVANCED SARCOMAS.CREAGAN ET; HAHN RG; AHMANN DL et al.1977; ONCOLOGY; SUISSE; DA. 1977; VOL. 34; NO 2; PP. 90-91Article

PHASE II STUDY OF HIGH-DOSE TAMOXIFEN (NSC-180973) IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMACREAGAN ET; INGLE JN; AHMANN DL et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 7; PP. 1353-1354; BIBL. 18 REF.Article

PHASE II STUDY OF MITOLACTOL AND SEMUSTINE COMBINATION CHEMOTHERAPY FOR ADVANCED MALIGNANT MELANOMACREAGAN ET; AHMANN DL; SCHUTT AJ et al.1982; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 6; PP. 1425-1426; BIBL. 8 REF.Article

CONTROLLED EVALUATION OF ADRIAMYCIN (NSC-123127) IN PATIENTS WITH DISSEMINATED BREAST CANCERAHMANN DL; BISEL HF; EAGAN RT et al.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 6; PP. 877-882; BIBL. 7 REF.Article

ADRIAMYCIN CARDIOTOXICITY IN STAGE IV BREAST CANCER: POSSIBLE ENHANCEMENT WITH PRIOR LEFT CHEST RADIATION THERAPYKINSELLA TJ; AHMANN DL; GIULIANI ER et al.1979; INTERNATION. J. RAD. ONCOL. BIOL. PHYS.; USA; DA. 1979; VOL. 5; NO 11-12; PP. 1997-2002; BIBL. 24 REF.Article

COMPARATIVE STUDY OF METHYL-CCNU(NSC-95441) WITH CYCLOPHOSPHAMIDE (NSC-26271) AND 5-(3,3 DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) WITH VINCRISTINE (NSC-67574) IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMAAHMANN DL; HAHN RG; BISEL HF et al.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 451-453; BIBL. 5REF.Article

RELIEF OF PAIN BY ORAL MEDICATIONS. A CONTROLLED EVALUATION OF ANALGESIC COMBINATIONS = SOULAGEMENT DE LA DOULEUR PAR DES MEDICATIONS ORALES. UNE EVALUATION CONTROLEE D'ASSOCIATIONS ANALGESIQUESMOERTEL CG; AHMANN DL; TAYLOR WF et al.1974; J. AMER. MED. ASS.; U.S.A.; DA. 1974; VOL. 229; NO 1; PP. 55-59; BIBL. 6REF.Article

EVALUATION OF CYCLOPHOSPHAMIDE (NSC-26271) AND 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA (BCNU; NSC-409962) IN THE TREATMENT OF PATIENTS WITH INOPERABLE OR DISSEMINATED LUNG CANCERAHMANN DL; CARR DT; COLES DT et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 3; PP. 401-403; BIBL. 1REF.Serial Issue

A COMPARATIVE EVALUATION OF MARKETED ANALGESIC DRUGSMOERTEL CG; AHMANN DL; TAYLOR WF et al.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 286; NO 15; PP. 813-815; BIBL. 9REF.Serial Issue

PHASE II STUDY OF TAMOXIFEN IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMACREAGAN ET; INGLE JN; GREEN SJ et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 2-3; PP. 199-201; BIBL. 17 REF.Article

AN EVALUATION OF TWO SCHEDULES OF VP-16 AND ADRIAMYCIN IN PATIENTS WITH ADVANCED BREAST CANCERRUBIN J; DECKER DA; AHMANN DL et al.1980; ONCOLOGY; CHE; DA. 1980; VOL. 37; NO 3; PP. 149-151; BIBL. 8 REF.Article

RANDOMIZED PHASE II TRIAL OF RUBIDAZONE AND ADRIAMYCIN IN WOMEN WITH ADVANCED BREAST CANCERINGLE JN; AHMANN DL; O'FALLON JR et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 65; NO 11-12; PP. 1701-1705; BIBL. 11 REF.Article

PHASE II STUDY OF TRIAZINATE AND PYRAZOFURIN IN PATIENTS WITH ADVANCED BREAST CANCER PREVIOUSLY EXPOSED TO CYTOTOXIC CHEMOTHERAPY.NICHOLS WC; KVOLS LK; INGLE JN et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 5; PP. 837-839; BIBL. 7 REF.Article

PHASE II EVALUATION OF VP-16-213 (NSC-141540) AND CYTEMBENA (NSC-104801) IN PATIENTS WITH ADVANCED BREAST CANCERAHMANN DL; BISEL HF; EAGAN RT et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 633-635; BIBL. 1 REF.Article

A PHASE I STUDY OF CYTEMBENAFRYTAK S; MOERTEL CG; SCHUTT AJ et al.1976; CANCER; U.S.A.; DA. 1976; VOL. 37; NO 3; PP. 1248-1255; BIBL. 10 REF.Article

PHASE II STUDY OF CHLOROZOTOCIN IN ADVANCED BREAST CANCEREDMONSON JH; GREEN SJ; INGLE JN et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 5-6; PP. 537-538; BIBL. 3 REF.Article

COMPLETE RESPONDERS TO CHEMOTHERAPY IN METASTATIC BREAST CANCER: CHARACTERIZATION AND ANALYSISDECKER DA; AHMANN DL; BISEL HF et al.1979; J.A.M.A.; USA; DA. 1979; VOL. 242; NO 19; PP. 2075-2079; BIBL. 15 REF.Article